Clonal Analyses Reveal Associations of JAK2V617F Homozygosity With Hematologic Features, Age and Gender in Polycythemia Vera and Essential Thrombocythemia

Haematologica - Italy
doi 10.3324/haematol.2012.079129
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)

Related search

Updates in the Management of Polycythemia Vera and Essential Thrombocythemia

Therapeutic Advances in Hematology
Hematology
2019English

Pegylated Interferon Alfa-2a Yields High Rates of Hematologic and Molecular Response in Patients With Advanced Essential Thrombocythemia and Polycythemia Vera

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2009English

Myocardial Infarction as a Thrombotic Complication of Essential Thrombocythemia and Polycythemia Vera

Anatolian journal of cardiology
Cardiovascular MedicineCardiology
2016English

Polycythemia Vera and Essential Thrombocythemia: 2019 Update on Diagnosis, Risk-Stratification and Management

American Journal of Hematology
Hematology
2018English

Hydroxyurea (HU) Is Effective in Reducing JAK2V617F Mutated Clone Size in the Peripheral Blood of Essential Thrombocythemia (ET) and Polycythemia Vera (PV) Patients

Annals of Hematology
MedicineHematology
2008English

Vitamin D Deficiency and Janus Kinase 2 V617F Mutation Status in Essential Thrombocythemia and Polycythemia Vera

Malaysian Journal of Medical Sciences
Medicine
2020English

Erlotinib Effectively Inhibits JAK2V617F Activity and Polycythemia Vera Cell Growth

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2006English

Alox5 Blockade Eradicates JAK2V617F -Induced Polycythemia Vera in Mice

Cancer Research
Cancer ResearchOncology
2016English

Bone Marrow Renin-Angiotensin System Expression in Polycythemia Vera and Essential Thrombocythemia Depends on JAK2 Mutational Status

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy